Planned
UmbrellaMax - BO44273 (Roll Over IMBRELLA B)
This is an open-label, multicenter, extension study to provide continued treatment with Roche investigational medicinal products (IMP[s]) monotherapy or in combination with other agent(s) or comparator agent(s) for eligible participants with cancer who were previously enrolled and treated in a Genentech- or Roche-sponsored study (the parent study) and who do not have access to the study treatment locally.
- Principal investigator : Prof. Dr. H. Dumez
- Sponsor : ROCHE
- More information :
- Indication :
- Internal reference number : S72162
Ongoing
IMBRELLA-B BO40729
An open label, multicenter extension study in patients previously enrolled in a genentech and/or F. Hoffmann-La Roche LTD sponsored Atezolizumab study (Imbrella B)
- Principal investigator : Prof. Dr. O. Bechter
- Sponsor : Hoffmann-La-Roche
- More information : NCT03768063
- Indication :
- Internal reference number : s63702
Closed
There are currently no closed studies in our center.